Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-096635
Filing Date
2019-04-03
Accepted
2019-04-03 16:10:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d710502d424b5.htm 424B5 430148
2 GRAPHIC g710502g76n76.jpg GRAPHIC 45522
3 GRAPHIC g710502g85h57.jpg GRAPHIC 43168
  Complete submission text file 0001193125-19-096635.txt   553501
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-224418 | Film No.: 19729069
SIC: 2836 Biological Products, (No Diagnostic Substances)